We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiologists, Vendors, Look beyond PACS and RIS

By HospiMedica International staff writers
Posted on 02 Mar 2011
There is an ongoing debate whether picture archiving and communication system (PACS) and radiology information system (RIS) usage qualifies under the "meaningful use"' criteria decreed by the Health Information Technology and Clinical Health Act (HITECH) in the United States. More...
This controversy, however, points at a much broader issue: the future of PACS and RIS, according to a recent market report.

Over the past 10 years, radiology departments have become increasingly standalone; so much so that a radiology department can now be operated by one company while its encompassing hospital is run by another, according to two reports from InMedica (Wellingborough, UK), a medical device market research company. Meaningful use suggests a need for change to bring radiology back into the hospitals with a centrally coordinated and multicentric healthcare information technology (IT) system; one that focuses on both end-user and patient, while providing easier access to PACS images within electronic medical records (EMRs).

This is not just an issue in the United States. In Europe, cross-border healthcare provision with interoperable healthcare IT is central to the European Union (EU) health strategy. In January 2011, the European Commission passed the directive on cross-border healthcare provision, allowing European citizens to receive care in any of the 27 member countries. eHealth, EMRs, and interoperability are central to this aim; the ability of hospitals to access electronic patient data anywhere in the European Union will be irrespective of healthcare systems, PACS or EMR vendor, and data will be accessed via a central platform.

Demand for these systems is clearly growing: In December 2010, the United States and European Union agreed to promote a common approach to interoperable eHealth; the Eleventh Annual European Interoperability Testing Event (IHE Connectathon) is being held in April 2011; and epSOS, the pilot program setting the framework of European interoperability is due to be completed in July 2011.

According to two InMedica reports, eHealth projects, starting at a national level, are forecast from 2011. These will lead to greater focus by PACS vendors on the hospital and not just radiology. Some vendors are already expanding their portfolio to include health information exchange (HIE) systems. Others will need to ensure PACS product development is focused towards vendor-neutral interoperability.

Related Links:

InMedica



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Adhesive
MED 5570U
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.